Cees G M Kallenberg Selected Research

Microscopic Polyangiitis

1/2018	Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
11/2017	Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.
12/2016	Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
4/2015	Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
10/2014	Advances in pathogenesis and treatment of ANCA-associated vasculitis.
8/2014	Key advances in the clinical approach to ANCA-associated vasculitis.
2/2014	The diagnosis and classification of microscopic polyangiitis.
12/2013	Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
2/2013	Renal vasculitis in 2012: reclassification and the introduction of biologicals.
1/2013	Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cees G M Kallenberg Research Topics

Disease

54	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2022 - 11/2004
51	Vasculitis (Vasculitides) 02/2022 - 01/2002
36	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2018 - 02/2002
21	Inflammation (Inflammations) 02/2022 - 01/2002
19	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014 - 04/2002
18	Microscopic Polyangiitis 01/2018 - 02/2002
13	Glomerulonephritis 01/2017 - 01/2002
11	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 10/2003
9	Rheumatoid Arthritis 01/2011 - 02/2004
8	Systemic Vasculitis 01/2016 - 12/2006
8	Churg-Strauss Syndrome (Allergic Angiitis) 08/2014 - 02/2002
6	Lupus Nephritis 01/2016 - 09/2008
5	Proteinuria 01/2018 - 05/2011
5	Human Influenza (Influenza) 11/2011 - 04/2007
4	Infections 03/2011 - 02/2009
4	Tic Disorders (Tic Disorder) 06/2007 - 08/2003
3	Hemorrhage 11/2019 - 07/2010
3	Granuloma 12/2013 - 02/2009
3	Ankylosing Spondylitis 05/2012 - 06/2011
3	Necrosis 11/2011 - 06/2004
3	Hypoxia (Hypoxemia) 03/2010 - 06/2007
2	Takayasu Arteritis (Arteritis, Takayasu's) 10/2017 - 11/2015
2	Purpura 11/2015 - 05/2010
2	Systemic Scleroderma (Systemic Sclerosis) 01/2014 - 07/2009
2	Atherosclerosis 01/2014 - 09/2010
2	Disease Progression 08/2012 - 05/2012
2	Arthritis (Polyarthritis) 05/2012 - 06/2011
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2011 - 01/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2010 - 07/2003
2	Tics (Tic) 06/2007 - 04/2004
1	Venous Thromboembolism 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Renal Insufficiency (Renal Failure) 01/2018
1	Hematuria 01/2018
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2015
1	Giant Cell Arteritis (Horton Disease) 11/2015
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 06/2015
1	Carotid Artery Diseases 01/2014
1	Staphylococcal Infections 12/2013
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2013
1	Rheumatic Diseases (Rheumatism) 11/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2012

Drug/Important Bio-Agent (IBA)

69	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2022 - 01/2002
27	AutoantibodiesIBA 01/2018 - 02/2002
26	Myeloblastin (Proteinase 3)IBA 11/2019 - 01/2002
24	Rituximab (Mabthera)FDA Link 11/2019 - 01/2010
16	Biomarkers (Surrogate Marker)IBA 02/2022 - 11/2010
14	Peroxidase (Myeloperoxidase)IBA 01/2018 - 02/2002
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019 - 07/2010
8	Azathioprine (Imuran)FDA LinkGeneric 11/2019 - 08/2009
7	CytokinesIBA 01/2018 - 11/2004
7	HMGB1 Protein (HMG1)IBA 12/2015 - 05/2011
7	AntibodiesIBA 12/2013 - 03/2006
6	Proteins (Proteins, Gene)FDA Link 01/2014 - 08/2003
5	Complement System Proteins (Complement)IBA 11/2015 - 05/2010
5	AutoantigensIBA 02/2013 - 10/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 08/2005
4	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 02/2009
4	Advanced Glycation End ProductsIBA 01/2011 - 05/2009
3	ChemokinesIBA 10/2017 - 11/2004
3	GlucocorticoidsIBA 01/2017 - 07/2010
3	EnzymesIBA 01/2017 - 02/2009
3	Prednisone (Sone)FDA LinkGeneric 01/2017 - 08/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 01/2002
3	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2010 - 04/2007
3	Monoclonal AntibodiesIBA 05/2010 - 08/2004
3	Interleukin-17 (Interleukin 17)IBA 01/2010 - 07/2008
2	LipidsIBA 11/2019 - 01/2014
2	Etanercept (Enbrel)FDA Link 12/2016 - 08/2011
2	CreatinineIBA 04/2015 - 02/2013
2	Immunoglobulin G (IgG)IBA 02/2015 - 10/2007
2	Interferon Type IIBA 01/2014 - 01/2014
2	Receptor for Advanced Glycation End ProductsIBA 01/2014 - 05/2009
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2013 - 03/2010
2	Biological ProductsIBA 02/2013 - 08/2012
2	interleukin-21 (interleukin 21)IBA 01/2013 - 01/2011
2	C-Reactive ProteinIBA 06/2011 - 06/2007
2	Antigen-Antibody Complex (Immune Complex)IBA 05/2010 - 10/2003
2	Transcription Factors (Transcription Factor)IBA 03/2010 - 06/2007
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 05/2009 - 06/2007
2	EpitopesIBA 03/2008 - 11/2003
2	E-SelectinIBA 03/2008 - 10/2005
2	Matrix Metalloproteinases (MMPs)IBA 12/2007 - 06/2004
2	Tissue Inhibitor of Metalloproteinase-1IBA 12/2007 - 06/2004
2	Fc gamma receptor IIAIBA 07/2003 - 05/2002
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017
1	Nucleosomes (Nucleosome)IBA 03/2016
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015
1	ProteomeIBA 01/2014
1	Blood Proteins (Serum Proteins)IBA 08/2013
1	AlarminsIBA 01/2013
1	Edetic Acid (EDTA)FDA Link 11/2012

Therapy/Procedure

12	Therapeutics 01/2018 - 11/2004
7	Remission Induction 01/2017 - 07/2010
1	Precision Medicine 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2015